oxazoles has been researched along with Pancreatic Neoplasms in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Ge, Y; He, X; Lei, W; Ma, Y; Mou, X; Ru, G; Wang, S; Wang, Y; Wei, B | 1 |
| Brito, JP; Gionfriddo, MR; Leppin, AL; Montori, VM; Morey-Vargas, OL; Murad, MH | 1 |
| Han, H; Stephens, B; Von Hoff, DD; Wang, H | 1 |
| Chow, HH; Dorr, RT; Flynn, G; Han, H; Henderson, MC; Hurley, LH; Samulitis, B; Shaw, AY; Stratton, SP | 1 |
| Griffin, EM; Shipman, M; Turner, PA; Whatmore, JL | 1 |
| Habara, Y; Moustafa, A; Sakamoto, KQ | 1 |
| Davenport, R; Herald, DL; Knight, JC; Pettit, GR; Pettit, RK; Schmidt, JM; Tucker, BE | 1 |
| Dono, K; Fujiwara, Y; Hayashi, N; Hiraoka, N; Monden, M; Nagano, H; Nakamori, S; Okami, J; Sakon, M; Tsujie, M; Umeshita, K; Yamamoto, H | 1 |
| Hurley, LH; Liu, W; Sun, D | 1 |
| Esumi, H; Ikeda, D; Kawada, M; Kunimoto, S; Masuda, T; Ohba, S; Osono, M | 1 |
| Allen, L; Meck, R; Yunis, A | 1 |
| Allen, LM; Clubb, KJ; Meck, RA; Yunis, AA | 1 |
| Berggren, PO; Honkanen, RE; Sjöholm, A | 1 |
| Hayakawa, T; Kamiya, N; Noda, A; Takayama, T | 1 |
| Hayakawa, T; Nakajima, S; Noda, A; Suzuki, T; Toda, Y | 1 |
2 review(s) available for oxazoles and Pancreatic Neoplasms
| Article | Year |
|---|---|
Systematic reviews to ascertain the safety of diabetes medications.
Topics: Acidosis, Lactic; Blood Glucose; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Female; Fractures, Bone; Glycated Hemoglobin; Glycine; Humans; Hypoglycemic Agents; Male; Meta-Analysis as Topic; Metformin; Oxazoles; Pancreatic Neoplasms; Risk Assessment; Rosiglitazone; Thiazolidinediones; Urinary Bladder Neoplasms | 2014 |
[Diagnosis of pancreatic diseases: Biochemical tests].
Topics: Anticonvulsants; Cholecystokinin; Chronic Disease; Humans; Oxazoles; Pancreas; Pancreatic Cyst; Pancreatic Diseases; Pancreatic Juice; Pancreatic Neoplasms; Pancreatitis; Secretin; Trimethadione | 1973 |
13 other study(ies) available for oxazoles and Pancreatic Neoplasms
| Article | Year |
|---|---|
Synergistic antitumor effects of CDK inhibitor SNS‑032 and an oncolytic adenovirus co‑expressing TRAIL and Smac in pancreatic cancer.
Topics: Adenoviridae; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle Checkpoints; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Gene Expression; Genetic Therapy; Genetic Vectors; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mitochondrial Proteins; Oncolytic Virotherapy; Oncolytic Viruses; Oxazoles; Pancreatic Neoplasms; Signal Transduction; Thiazoles; TNF-Related Apoptosis-Inducing Ligand; Xenograft Model Antitumor Assays | 2017 |
Identification and characterization of a novel anticancer agent with selectivity against deleted in pancreatic cancer locus 4 (DPC4)-deficient pancreatic and colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclin B; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Flow Cytometry; Genotype; HCT116 Cells; Humans; Inhibitory Concentration 50; Molecular Structure; Oxazoles; Pancreatic Neoplasms; Phosphorylation; Smad4 Protein; Tumor Stem Cell Assay; Xanthones | 2009 |
Characterization of novel diaryl oxazole-based compounds as potential agents to treat pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; DNA, Neoplasm; Drug Design; Drug Stability; Humans; Kinesins; Magnetic Resonance Spectroscopy; Male; Mice; Mice, SCID; Necrosis; Neoplasm Proteins; Neoplasm Transplantation; Oxazoles; Pancreatic Neoplasms; Protein Binding; Proto-Oncogene Mas; Structure-Activity Relationship | 2009 |
Tetrahydroxanthones by sequential Pd-catalyzed C-O and C-C bond construction and use in the identification of the "antiausterity" pharmacophore of the kigamicins.
Topics: Antineoplastic Agents; Catalysis; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Oxazoles; Palladium; Pancreatic Neoplasms; Xanthones | 2011 |
A fundamental role for NO-PLC signaling pathway in mediating intracellular Ca2+ oscillation in pancreatic acini.
Topics: Animals; Calcium; Carcinoma, Acinar Cell; Estrenes; Inositol 1,4,5-Trisphosphate; Macrocyclic Compounds; Male; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Oxadiazoles; Oxazoles; Pancreatic Neoplasms; Phosphodiesterase Inhibitors; Pyrrolidinones; Quinoxalines; Rats; Rats, Wistar; Signal Transduction; Sincalide; Type C Phospholipases | 2011 |
Isolation of labradorins 1 and 2 from Pseudomonas syringae pv. coronafaciens.
Topics: Crystallography, X-Ray; Deoxycholic Acid; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Oxazoles; Pancreatic Neoplasms; Pseudomonas; Tumor Cells, Cultured | 2002 |
Suppression of pancreatic cancer cell invasion by a cyclooxygenase-2-specific inhibitor.
Topics: Benzenesulfonates; Cell Adhesion; Cell Division; Cell Movement; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation; Humans; Isoenzymes; Matrix Metalloproteinases; Membrane Proteins; Neoplasm Invasiveness; Oxazoles; Pancreatic Neoplasms; Prostaglandin-Endoperoxide Synthases; Tumor Cells, Cultured | 2003 |
Binding of G-quadruplex-interactive agents to distinct G-quadruplexes induces different biological effects in MiaPaCa cells.
Topics: Anaphase; Angiogenesis Inhibitors; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Oxazoles; Pancreatic Neoplasms; Porphyrins | 2005 |
Antitumor effect of kigamicin D on mouse tumor models.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Colonic Neoplasms; Disease Models, Animal; Doxorubicin; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Oxazoles; Pancreatic Neoplasms; Xenograft Model Antitumor Assays | 2006 |
The inhibition of gamma-glutamyl transpeptidase from human pancreatic carcinoma cells by (alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501).
Topics: Antibiotics, Antineoplastic; Cells, Cultured; gamma-Glutamyltransferase; Glycine; Half-Life; Humans; Isoxazoles; Oxazoles; Pancreatic Neoplasms; Time Factors | 1980 |
Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501).
Topics: Cell Count; Cell Division; Cell Line; Cell Survival; Colony-Forming Units Assay; DNA; Dose-Response Relationship, Drug; Humans; Interphase; Isoxazoles; Kinetics; Male; Oxazoles; Pancreatic Neoplasms; Time Factors | 1981 |
Characterization of serine/threonine protein phosphatases in RINm5F insulinoma cells.
Topics: Animals; Ethers, Cyclic; In Vitro Techniques; Insulinoma; Marine Toxins; Microcystins; Okadaic Acid; Oxazoles; Pancreatic Neoplasms; Peptides, Cyclic; Phosphoprotein Phosphatases; Rabbits; Rats; Tumor Cells, Cultured | 1993 |
Pancreatolithiasis and pancreatic carcinoma. Evaluation of pancreatic excretion test with 5,5-dimethyl-2,4-oxazolidinedione.
Topics: Calculi; Cholecystokinin; Dimethadione; Duodenum; Humans; Oxazoles; Pancreatic Diseases; Pancreatic Neoplasms; Secretin; Trimethadione | 1977 |